← Open Payments lookup

TERESA GOODNER: Open Payments

NPI 1841812260 · SOUTH JORDAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,272 in 62 payments from 13 companies in 2025. Trend: 2023 $707 · 2024 $693 · 2025 $2,272

Food & beverage: $1,542Travel & lodging: $729
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc15$1,112
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$394
ABBVIE INC.7$167
Tris Pharma Inc6$112
Vanda Pharmaceuticals Inc.3$106
E.R. Squibb & Sons, L.L.C.5$88
Takeda Pharmaceuticals U.S.A., Inc.3$68
Teva Pharmaceuticals USA, Inc.3$55
Axsome Therapeutics, Inc.2$45
Neurocrine BioSciences, Inc.2$42

Products named: SPRAVATO, CAPLYTA, VRAYLAR, Dyanavel XR, FANAPT, COBENFY, REXULTI, TRINTELLIX.

Industry payments across UT — which companies pay providers there.